Harnessing NKT cells for therapeutic applications

Citations of this article
Mendeley users who have this article in their library.
Get full text


Activation of NKT cells leads to the maturation of dendritic cells and effficiently assists priming of antigen-specific immune responses. The lack of polymorphism of CD1d molecules and the evolutionary conservation of NKT cell responses highlight the important role of these cells in bridging innate and adaptive immune responses and advocate the value of harnessing this system in clinical settings. Compounds capable of fine tuning NKT cell activation should be actively exploited as potent adjuvants in vaccination strategies or as immunomodulators of autoimmune diseases. © Springer-Verlag 2007.




Cerundolo, V., & Salio, M. (2007). Harnessing NKT cells for therapeutic applications. Current Topics in Microbiology and Immunology. Springer Verlag. https://doi.org/10.1007/978-3-540-69511-0_13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free